PRTA
Prothena Corporation PLC
Price:  
13.81 
USD
Volume:  
291,437.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA EV/EBITDA

-274.9%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Prothena Corporation PLC (PRTA) is -1.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTA's latest enterprise value is 223.85 mil USD. PRTA's TTM EBITDA according to its financial statements is -167.68 mil USD. Dividing these 2 quantities gives us the above PRTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.1x - 13.7x 10.1x
Forward P/E multiples 9.3x - 16.4x 11.6x
Fair Price (19.27) - (32.92) (24.16)
Upside -239.5% - -338.4% -274.9%
13.81 USD
Stock Price
(24.16) USD
Fair Price

PRTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-29 -2.11
2024-11-27 -2.00
2024-11-26 -1.90
2024-11-25 -1.74
2024-11-22 -1.59
2024-11-21 -1.54
2024-11-20 -1.52
2024-11-19 -1.41
2024-11-18 -1.24
2024-11-15 -1.40
2024-11-14 -2.07
2024-11-13 -2.43
2024-11-12 -2.47
2024-11-11 -2.71
2024-11-08 -2.58
2024-11-07 -2.52
2024-11-06 -2.79
2024-11-05 -2.32
2024-11-04 -2.19
2024-11-01 -2.25
2024-10-31 -2.36
2024-10-30 -2.71
2024-10-29 -2.77
2024-10-28 -2.55
2024-10-25 -1.81
2024-10-24 -2.12
2024-10-23 -2.23
2024-10-22 -2.21
2024-10-21 -2.20
2024-10-18 -2.39
2024-10-17 -2.38
2024-10-16 -2.40
2024-10-15 -2.33
2024-10-14 -2.46
2024-10-11 -2.43
2024-10-10 -2.29
2024-10-09 -2.18
2024-10-08 -2.26
2024-10-07 -2.23
2024-10-04 -2.31
2024-10-03 -2.29
2024-10-02 -2.26
2024-10-01 -2.25
2024-09-30 -2.27
2024-09-27 -3.34
2024-09-26 -3.37
2024-09-25 -3.46
2024-09-24 -3.97
2024-09-23 -3.96
2024-09-20 -3.84